The pharmaceutical industry widely uses antibodies to create drugs, such as for cancer and coronaviruses. But creating the ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

As drug development enters a new era, Certara is expanding its global team of scientists and technologists to lead the shift toward AI-powered testing methods.

The FDA awards a second round of Commissioner’s National Priority vouchers to six larger biopharma companies. And this time, ...

The Lupus Research Alliance (LRA), through its Lupus Accelerating Breakthroughs Consortium (Lupus ABC)—a public-private ...

Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Shanghai ZJ Bio-Tech technology Co., Ltd. (hereinafter referred to as "Shanghai ZJ Bio-Tech") jointly announced the official signing of a ...

In contrast, by utilizing technology-driven tools more effectively, we can drive efficiencies, improve communication, and ...

Efficient cell line development remains one of the most critical challenges in biotherapeutic manufacturing. Achieving stable ...

Pharmacist and PhD researcher Hannah Cleary tells us about her work on long-acting injectables (LAIs) to improve drug ...

CHENNAI: The researchers from Indian Institute of Technology Madras and The Ohio State University, US, have developed a breakthrough Artificial Intelligence (AI ...

CHARLOTTETOWN, Prince Edward Island & WORCESTER, Mass., November 06, 2025--This partnership provides a fully integrated ...

EMA’s PRIME designation bolsters Neurona’s global development strategy and underscores the company’s commitment to bringing NRTX-1001 interneuron cell therapy to patients worldwide.